Polyplus
Created in 2001
Social networks
249 10,271 10,271Activities
Technologies
Entity types
Location
75 Rue Marguerite Perey, 67400 Illkirch-Graffenstaden, France
Illkirch-Graffenstaden
France
Employees
Scale: 51-200
Estimated: 167
SIREN
434320479Engaged corporates
4
3 1Added in Motherbase
3 years, 6 months ago
biotech Value proposition
We power your science
Polyplus is a leading upstream solutions provider for advanced biologic and cell and gene therapy production from research to commercial scale. An innovator in nucleic acid delivery, the legacy portfolio features process-centric transfection reagents, kits, and support services. Custom plasmid vector design was integrated into the offer in 2022 as a first measure to expanding the products and services portfolio to help customers (or the industry) optimize process economics while meeting strict scientific and regulatory standards. Headquartered in Europe, the Polyplus team continues to grow globally with operations in the United States and Asia.
Research, DNA, Transfection, Gene expression, Bioproduction, Life sciences, Biotechnology, RNA interference, Science, Biology, Protein production, Virus production, Cell culture, CRISPR, and BiotechnologyOriginal language
We power your science
Polyplus is a leading upstream solutions provider for advanced biologic and cell and gene therapy production from research to commercial scale. An innovator in nucleic acid delivery, the legacy portfolio features process-centric transfection reagents, kits, and support services. Custom plasmid vector design was integrated into the offer in 2022 as a first measure to expanding the products and services portfolio to help customers (or the industry) optimize process economics while meeting strict scientific and regulatory standards. Headquartered in Europe, the Polyplus team continues to grow globally with operations in the United States and Asia.
Polyplus® | Expertise - Quality - Support
Polyplus is a leading upstream solutions provider for advanced biologic and cell and gene therapy production from research to commercial scale. An innovator in nucleic acid delivery, the legacy portfolio features process-centric transfection reagents, kits, and support services.
https://www.polyplus-sartorius.com/?utm_source=LinkedIn&utm_medium=button&utm_id=static
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 SEMIA Startup accelerator & VC, Business Consulting and Services | SEMIA Startup accelerator & VC, Business Consulting and Services | Other 8 Apr 2023 | | |
 SATT CONECTUS Research, Research Services | SATT CONECTUS Research, Research Services | Other 3 Apr 2023 | | |
 Regeneron Pharmaceutical, Biotechnology, Biotechnology Research | Regeneron Pharmaceutical, Biotechnology, Biotechnology Research | Other 21 Feb 2023 | | |
 La French Tech Est Startup accelerator & VC, French Tech, Business Consulting and Services | La French Tech Est Startup accelerator & VC, French Tech, Business Consulting and Services | Not capitalistic Not partnership Event 4 Jun 2018 | | |